Cities that participated in the 2021 national opioid settlement agreements are now eligible to join five new national opioid settlements with CVS, Walgreens, Walmart, Teva and Allergan.
Eligible cities received an email notification about the new agreements on January 25, 2023 from Rubris, the third-party settlement Implementation Administrator (OpioidSettlements@rubris.com). During the month of February, those cities will receive a second email from the Administrator with a Participation Form for each settlement. City representatives have until April 18, 2023 to execute and return the Participation Forms to the Administrator. The Participation Forms were emailed out on February 8 and were sent by “Opioids Implementation Administrator” with the email address opioidsparticipation@rubris.com.”
Iowa subdivisions achieved a remarkable 100% participation rate in the first set of national opioid settlements and it is critically important for all eligible cities to join these new settlements as well. The greater the rate of participation by cities and counties, the more funds will come to the State, which can receive up to $345 million dollars over a multi-year period through these agreements. The funds will be allocated among the State and participating Iowa subdivisions under the Iowa Opioid Memorandum of Understanding and must be used to abate the opioid crisis through prevention and treatment.
The State of Iowa has already joined the new settlements. State funds are held in the Opioid Settlement Fund established in 2022 and must be used for abatement purposes. More information and settlement documents can be found on the Attorney General’s website (www.iowaattorneygeneral.gov) and the National Opioid Settlement website (www.nationalopioidsettlement.com). If you have questions, please contact the Iowa Attorney General’s office by emailing OpioidSettlement@ag.iowa.gov or calling Assistant Attorney General Amy Licht at (515) 281-5926.
